Navigation Links
VIVUS Provides Regulatory Update on QNEXA
Date:9/15/2011

MOUNTAIN VIEW, Calif., Sept. 15, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that following a recent teleconference it has reached agreement with officials of the Endocrine and Metabolic Division of the Food and Drug Administration on a plan that allows for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. The resubmission plan allows VIVUS to seek approval for an initial indication that includes obese men and women of non-child bearing potential.  Based on this agreement, VIVUS intends to resubmit the QNEXA NDA by the end of October 2011, prior to completion of the FORTRESS study. Top-line results from FORTRESS are expected in December 2011, with validation of FORTRESS expected in the third quarter of 2012. The FDA also stated that an Advisory Committee meeting for QNEXA will be held in the first quarter of 2012.

"Recent epidemiology study results, which show that topiramate is not a major teratogen, were an important consideration in our plan to resubmit the QNEXA NDA ahead of the FORTRESS results. The planned October resubmission will also allow for an early 2012 Advisory Committee meeting and a second quarter 2012 PDUFA date," commented Peter Y. Tam, president of VIVUS. "In this initial indication, we plan to include a contraindication for women of childbearing potential. We believe this is a sound approach that, if approved, will potentially allow early commercialization in a higher-risk population with a significant unmet medical need.  The FORTRESS study remains important in our plan to more precisely define the teratogenic potential of topiramate and may enable us to expand the indication to include obese women of child-bearing potential.  If the FORTRESS results are favorable, we expect to file for the full indication in late 2012."

According to the CDC, over 108 million adult Americans are
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
2. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
3. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
4. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
5. VIVUS to Present at Three Upcoming Investor Conferences in March
6. VIVUS Provides Regulatory Update on QNEXA NDA
7. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
8. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
9. VIVUS to Present at Two Upcoming Investor Conferences
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  Cohen, Placitella & Roth, ... investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or ... period from January 31, 2011 through November 2, ... and certain of its officers and directors publically ... of Sections 10(b) and 20(a) of the Securities ...
(Date:11/26/2014)... 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... and Drug Administration (FDA) has issued a Complete ... for AVP-825. AVP-825 is an investigational drug-device combination ... utilizing a novel Breath Powered delivery technology. ... consistent with the preliminary feedback announced on November ...
(Date:11/26/2014)... Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... and Chief Executive Officer, will present at the Bank of America ... , , Date: , , , Wednesday, December 3, 2014 ... EST , , , , Location: , , , Boca ... About BioScrip, Inc. BioScrip, Inc. is a ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
... FORT WASHINGTON, Pa., July 28, 2011 ... announced plans for new dosing instructions lowering the maximum ... in the U.S. from 8 pills per day (4,000 ... change is designed to help encourage appropriate acetaminophen use ...
... Inc. (NYSE: CRY ), a leading tissue ... surgery, announced today its results for the second quarter and ... were a record $29.4 million compared to $29.3 million for ... months increased to a record of $59.6 million compared to ...
Cached Medicine Technology:McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products 2McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products 3CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 2CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 3CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 4CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 5CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 6CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 7CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 8CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 9CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 10CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 11CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 12CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 13CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 14CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 15CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 16CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 17CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 18
(Date:11/27/2014)... (PRWEB) November 27, 2014 TORQ Cycle is ... professional instructors who go out of the way to help ... people to get fit and do their workouts sincerely using ... they understand the fact that it is important for people ... past year, they have made sure that people take to ...
(Date:11/27/2014)... The American Society for Clinical Pathology (ASCP) announced ... honor of World AIDS Day 2014. On Nov. 25, ASCP ... icon and infographic designed to generate public awareness about World ... , ASCP has asked members to replace their Facebook, Twitter, ... Tested. Find a cure.” icon and share the accompanying infographic ...
(Date:11/27/2014)... Absolute PhysioCare & Sports Rehab, a ... personalized treatment plans, highly skilled and educated therapists ... sports injuries reach pre-injury state. Whether it is ... Absolute Physio has the right treatment for it. ... meniscal injuries, groin strain and sports hernia can ...
(Date:11/27/2014)... Luciana Lagana and her husband Gregory ... feature film that received 9 awards at the 2014 Zed ... It is also an official selection of the 2014 PollyGrind ... cinematic career for James Noel, a young filmmaker who excels ... mystery, filmed in glorious black and white, watching Omadox will ...
(Date:11/27/2014)... Acapulco, Guerrero (PRWEB) November 27, 2014 ... the time individuals allot to sleep has lessened, ... televisions and laptops, the quality of sleep has ... workers falls asleep on the job (Reference: ... American worker’s productivity index by an incalculable amount, ...
Breaking Medicine News(10 mins):Health News:The new wave in Fitness : Stay Active with Innovative Indoor Cycling Programs 2Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:Coquitlam Physiotherapy Clinic Now Helps Clients Reach Pre-Injury State 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... Feb. 10 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the ... China-based medical device,company that develops, manufactures and markets ... report its unaudited financial results,for the third fiscal ... U.S. market opens on March 2, 2009. ...
... bed nets to four refugee camps in Kenya , ... ... The United Nations Foundation,s Nothing But Nets campaign, a ... successfully raised more than $1.2 million to provide long-lasting insecticide-treated nets ...
... exciting opportunities in occupational therapy. , ... ... Health Schools announces the launch of their latest resource center ... and education, the new resource center can be found at ...
... Jason Baron, M.D. of Med Labs Research leads research for local patients ... Houston, ... to concentrate and focus on the things you enjoy and important tasks that ... remember what you just talked about or learned a short time ago. ...
... and Kosher Raw Materials CatalogST. LOUIS, Feb. 10 ... member of the Sigma-Aldrich Group (Nasdaq: ... raw materials, today announced that it has added 50 ... Fragrances raw materials product line. Details of the ...
... ValueOptions(R) New Mexico, Inc., today filed a formal ... State of New Mexico,s managed behavioral health care contract ... a competitive bidding process.ValueOptions(R) New Mexico believes a stay ... its seriously mentally ill consumers who will be adversely ...
Cached Medicine News:Health News:China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009 2Health News:Nothing But Nets and Union of Reform Judaism Help Save Lives in Kenya 2Health News:New Occupational Therapy School and Career Resource on All Allied Health Schools 2Health News:New Occupational Therapy School and Career Resource on All Allied Health Schools 3Health News:New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 3Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 4Health News:ValueOptions(R) New Mexico Files Formal Protest of Award of New Mexico Behavioral Health Contract to United 2Health News:ValueOptions(R) New Mexico Files Formal Protest of Award of New Mexico Behavioral Health Contract to United 3Health News:ValueOptions(R) New Mexico Files Formal Protest of Award of New Mexico Behavioral Health Contract to United 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: